Reviva PharmaceuticalsRVPH
那斯達克 · USD
0.91
+0.06
(+7.22%)
收盤 04/21 03:58 (UTC+8)
盤後
0.92
+0.01
(+0.92%)
04/21 03:58 (UTC+8)
Reviva PharmaceuticalsRVPH
0.91
+0.06
(+7.22%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 3,559 | 4,029 | 6,073 | 6,539 | - | - | - | 7,922 | 9,619 | 11,195 |
研發費用 | 1,739 | 2,131 | 3,725 | 4,114 | 4,681 | 6,858 | 5,584 | 5,784 | 8,107 | 9,203 |
推銷及管理費用 | 1,820 | 1,898 | 2,348 | 2,425 | 1,604 | 1,604 | 2,545 | 2,138 | 1,512 | 1,992 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,559 | -4,030 | -6,073 | -6,538 | -6,285 | -8,463 | -8,130 | -7,922 | -9,619 | -11,195 |
其他收入及費用 | 189 | 25 | 32 | 122 | 35 | 102 | 282 | 499 | 239 | 230 |
利息費用 | -6 | 3 | 5 | 12 | 5 | 5 | 5 | 3 | -20 | - |
稅前純益 | -3,365 | -4,008 | -6,046 | -6,428 | -6,255 | -8,366 | -7,853 | -7,426 | -9,360 | -10,965 |
所得稅 | 3 | 3 | 8 | 5 | 5 | - | 7 | 7 | -5 | 12 |
稅後純益 | -3,368 | -4,011 | -6,054 | -6,433 | -6,259 | -8,366 | -7,860 | -7,434 | -9,355 | -10,977 |
基本每股稅後盈餘(元) | 0.04 | -0.06 | -0.12 | -0.13 | -0.14 | -0.25 | -0.26 | -0.25 | - | -0.44 |
稀釋每股稅後盈餘(元) | 0.02 | -0.04 | -0.12 | -0.13 | -0.14 | -0.24 | -0.26 | -0.25 | -0.33 | -0.48 |
基本平均股數(千股) | 119071.00 | 72685.00 | 49847.00 | 48644.00 | 38343.00 | 33804.00 | 30555.00 | 29887.00 | - | 24033.00 |
稀釋平均股數(千股) | - | 72685.00 | 49847.00 | 48644.00 | - | 33804.00 | 30555.00 | 29887.00 | - | 24033.00 |
還原基本每股稅後盈餘(元) | 0.72 | -1.20 | -2.40 | -2.60 | -2.80 | -5.00 | -5.20 | -5.00 | - | -8.80 |
還原稀釋每股稅後盈餘(元) | 0.32 | -0.80 | -2.40 | -2.60 | -2.73 | -4.80 | -5.20 | -5.00 | -6.60 | -9.60 |
還原基本平均股數(千股) | 5,953 | 3,634 | 2,492 | 2,432 | 1,917 | 1,690 | 1,527 | 1,494 | - | 1,201 |
還原稀釋平均股數(千股) | - | 3,634 | 2,492 | 2,432 | - | 1,690 | 1,527 | 1,494 | - | 1,201 |
EBITDA(千元) | -3,371 | -4,005 | -6,041 | -6,416 | -6,249 | -8,361 | -7,848 | -7,424 | -9,380 | -10,965 |